No, Assertio was not acquired by Zydus Lifesciences. Assertio operates as an independent, publicly traded specialty pharmaceutical corporation listed on the Nasdaq stock exchange. While major pharmaceutical firms frequently engage in product licensing, portfolio divestitures, or corporate transactions within the global healthcare sector, Assertio has maintained its standalone corporate identity under its own executive management team.